Lecture 6: Diuretic Agents Flashcards

1
Q

what is reabsorption of water very dependent on

A

Na+

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

what is the main site of action of carbonic anhydrase inhibitors

A

proximal tubule

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

what is the main site of action of osmotic diuretics

A
  • proximal tubule

- descending loop of henle

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

what is the main site of action of thiazides and thiazide like diuretics

A

early distal tubule

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

what is the main site of action of potassium sparing diuretics

A
  • late distal tubule

- early collecting tubule

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

example of a loop diuretic

A

furosemide

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

how do loop diuretics work

A
  • inhibit NKCC2 transporter in the thick ascending limb of loop of henle
  • reduced Na+ reabsorption leads to profound diuresis
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

unwanted effects of loop diuretic use

A
  • dehydration
  • hypokalaemia
  • metabolic alkalosis
  • hypokalaemia can potentiate effects of cardiac glycosides
  • deafness when used with aminoglycoside antibiotics
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

where do thiazide diuretics act

A
  • distal tubule

- on Na+/Cl- cotransporter

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

examples of thiazide diretics

A
  • bendroflumethiazide

- hydrochlorothiazide

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

examples of thiazide like diuretics

A
  • indapamide (preferred for hypertension)
  • metolazone (good combined with loop diuretic)
  • xipamide (lowers BP with less side effects)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

unwanted effects of thiazide diuretics

A
  • plasma K+ depletion
  • metabolic alkalosis
  • increased plasma uric acid and gout
  • hyperglycaemia
  • increased plasma cholesterol with long term use
  • reverisble male impotence
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

what is the current preferred diuretic for resistant hypertension

A

indapamide

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

symptoms of mild hypokalaemia

A
  • fatigue
  • drowsiness
  • dizziness
  • muscle weakness
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

symptoms of severe hypokalaemia

A
  • arrhythmias
  • muscle paralysis
  • death
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

examples of aldosterone antagonists

A
  • eplerenone

- spironolactone

17
Q

examples of non-aldosterone antagonists

A
  • amiloride

- triamterene

18
Q

what is the active metabolite of spironolactone

A

canrenone

19
Q

what are aldosterone antagonists used for

A
  • oedema

- heart failure

20
Q

unwanted effects of aldosterone antagonists

A
  • hyperkalaemia
  • metabolic acidosis
  • GI upsets
  • gynaecomastia, menstrual disorders, testicular atrophy
21
Q

how do non-aldosterone antagonists work

A

block luminal Na+ channel on distal tubule

22
Q

unwanted effects of non-aldosterone antagonists

A
  • hyperkalaemia
  • metabolic acidosis
  • GI issues
  • skin rashes
23
Q

example of carbonic anhydrase inhibitor

A

azetozolamide

24
Q

what are carbonic anhydrase inhibitors used for

A
  • glaucoma

- epilepsy

25
Q

unwanted effects of carbonic anhydrase inhibitors

A
  • metabolic acidosis

- enhances renal stone formation

26
Q

what were the potential ADH antagonists

A
  • lithium
  • demeclocycline
  • now developing tolvaptan
27
Q

issue with the ADH antagonists

A
  • can cause diabetes insipidus
  • can cause renal failure
  • lithium can cause tremors, mental confusion, cardiotoxicity
  • demeclocycline shouldn’t be used in patients with liver disease
28
Q

what is tolvaptan being used for

A
  • treatment of hyponatriuraemia

- in fast track clinical trials for polycystic kidney disease